Company Overview

U.S. Physical Therapy, Inc. is a publicly traded healthcare services company specializing in outpatient physical therapy and related rehabilitative services. The company operates within the healthcare services and rehabilitation industries, focusing primarily on musculoskeletal care delivered through independently branded clinics. Its core business involves partnering with physical therapists to operate outpatient clinics, with revenue primarily generated from patient treatment visits reimbursed by commercial insurers, workers’ compensation programs, and government payors.

Founded in 1990, the company pioneered a partnership-based model in which U.S. Physical Therapy, Inc. typically holds a majority ownership interest while local therapists retain meaningful equity and operational involvement. This structure is considered a strategic differentiator, supporting clinician retention, local market responsiveness, and scalable growth. Over time, the company expanded beyond traditional outpatient therapy into industrial injury prevention and onsite employer services, broadening its revenue base and end-market exposure.

Business Operations

The company conducts operations through two primary business segments: Outpatient Physical Therapy and Industrial Injury Prevention Services. The outpatient segment represents the majority of revenue and consists of hundreds of clinics operated through majority-owned partnerships under various local brand names. These clinics provide physical therapy, occupational therapy, and limited complementary services such as hand therapy and sports rehabilitation.

The industrial injury prevention segment delivers onsite and near-site services to employers, including injury prevention, ergonomic assessments, and functional testing. This segment operates nationally and serves large industrial and logistics customers. The company conducts business exclusively within the United States and operates through numerous clinic-level legal entities that function as subsidiaries or joint ventures under the corporate umbrella of U.S. Physical Therapy Network, Inc., its primary operating subsidiary.

Strategic Position & Investments

U.S. Physical Therapy, Inc. pursues a growth strategy centered on clinic acquisitions, de novo clinic development, and selective expansion of employer-focused injury prevention services. The company regularly acquires majority interests in established physical therapy practices, often allowing founding clinicians to retain minority ownership and clinical leadership. This disciplined acquisition strategy emphasizes cultural alignment, clinical outcomes, and local market density.

A notable strategic investment was the acquisition of Briotix Health, which significantly expanded the company’s industrial injury prevention platform and national employer relationships. The company continues to invest in clinic expansion, therapist recruitment, and operational infrastructure, while monitoring emerging care delivery models and value-based reimbursement trends. Public disclosures indicate no material international expansion initiatives at this time. Data inconclusive based on available public sources regarding material investments outside its core service lines.

Geographic Footprint

The company’s operations are concentrated across the United States, with outpatient clinics located in numerous states spanning the South, Midwest, West, and Northeast regions. While clinic density is higher in certain large and fast-growing states, no single state accounts for a majority of total revenue based on publicly available disclosures.

Corporate headquarters are located in Texas, and the industrial injury prevention segment supports employer clients with multi-state and national footprints. The company does not report owning or operating clinics outside the United States, and there is no verified evidence of direct international operations or foreign subsidiaries.

Leadership & Governance

U.S. Physical Therapy, Inc. was founded by Christopher J. Reading, who continues to play a central role in shaping the company’s long-term strategy and partnership-driven culture. Leadership emphasizes clinician alignment, decentralized operations, and conservative financial management. The board and executive team maintain oversight consistent with public company governance standards and healthcare regulatory requirements.

Key executives include:

• Christopher J. Reading – Chairman of the Board & Chief Executive Officer
• Graham D. Reeve – President
• Carey P. Hendrickson – Chief Financial Officer
• Brian M. Middleton – Chief Operating Officer

The leadership team’s stated strategic vision focuses on sustainable growth through therapist partnerships, operational consistency, and expansion of complementary services that align with employer and patient demand.